Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 18;27(18):6088.
doi: 10.3390/molecules27186088.

Production of Salvianic Acid A from l-DOPA via Biocatalytic Cascade Reactions

Affiliations

Production of Salvianic Acid A from l-DOPA via Biocatalytic Cascade Reactions

Ke Shun Hu et al. Molecules. .

Abstract

Salvianic acid A (SAA), as the main bioactive component of the traditional Chinese herb Salvia miltiorrhiza, has important application value in the treatment of cardiovascular diseases. In this study, a two-step bioprocess for the preparation of SAA from l-DOPA was developed. In the first step, l-DOPA was transformed to 3,4-dihydroxyphenylalanine (DHPPA) using engineered Escherichia coli cells expressing membrane-bound L-amino acid deaminase from Proteus vulgaris. After that, the unpurified DHPPA was directly converted into SAA by permeabilized recombinant E. coli cells co-expressing d-lactate dehydrogenase from Pediococcus acidilactici and formate dehydrogenase from Mycobacterium vaccae N10. Under optimized conditions, 48.3 mM of SAA could be prepared from 50 mM of l-DOPA, with a yield of 96.6%. Therefore, the bioprocess developed here was not only environmentally friendly, but also exhibited excellent production efficiency and, thus, is promising for industrial SAA production.

Keywords: biocatalysis; biological engineering; l-DOPA; membrane-bound l-amino acid deaminases; molecular biology; salvianic acid A.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic of the synthesis of salvianic acid A (SAA) from l-DOPA. DHPPA: 3,4-dihydroxyphenylalanine; ml-AAD: membrane-bound l-amino acid deaminases; d-LDH: d-lactate dehydrogenase; HPPR: hydroxyphenylpyruvate reductase; FDH: formate dehydrogenase.
Figure 2
Figure 2
SDS-PAGE analysis of ml-AAD expression in BL21(DE3)-pET-28a-mlaad. Lane 1, membrane fractions of BL21(DE3)-pET28a (control); lane 2, membrane fractions of BL21(DE3)-pET-28a-mlaad; The same amounts of cells were loaded in lane 1 and lane 2. Bands indicated by arrow, recombinant ml-AAD; the theoretical protein size was 51.5 kDa. Both BL21(DE3)-pET-28a-mlaad and the control were induced using 0.5 mM IPTG at 28 °C and 150 rpm for 6 h.
Figure 3
Figure 3
(a) Effects of pH on the relative yield of DHPPA (reactions were performed at 37 °C in reaction mixture comprised of 0.42 g·L−1 recombinant cells and 20 mM l-DOPA (pH 5–10); the DHPPA yield at pH 7.5 was set as 100%); (b) effects of temperature on the relative yield of DHPPA (reactions were performed at 22–55 °C in reaction mixture comprised of 0.42 g·L−1 recombinant cells and 20 mM l-DOPA (pH 7.5); the DHPPA yield at 37 °C was set as 100%); (c) effects of substrate concentration on the relative yield of DHPPA (reactions were performed at 37 °C in reaction mixture comprised of 0.42 g·L−1 recombinant cells and 20-100 mM l-DOPA (pH 7.5); the DHPPA yield at 50 mM l-DOPA was set as 100%); (d) effects of cell concentration on the relative yield of DHPPA (reactions were performed at 37 °C in reaction mixture comprised of 0.11–0.84 g·L−1 recombinant cells and 50 mM l-DOPA (pH 7.5); the DHPPA yield at 0.84 g·L−1 cell concentration was set as 100%). Data represent the means ± SD from three independent determinations.
Figure 4
Figure 4
Time profile for the production of DHPPA from l-DOPA using BL21(DE3)-pET-28a-mlaad whole-cell catalysts under optimal conditions. Data represent the means ± SD from three independent determinations.
Figure 5
Figure 5
SDS-PAGE analysis of total cell lysates and the soluble constituents of BL21(DE3)-pETDuet-dldh-fdh and BL21(DE3)-pETDuet-hppr-fdh. Total cell lysates of BL21(DE3) were used as control (lane 1); total cell lysates and soluble constituents of BL21(DE3)-pETDuet-dldh-fdh were loaded in lanes 2 and 4, respectively; total cell lysates and soluble constituents of BL21(DE3)-pETDuet-hppr-fdh were loaded in lanes 3 and 5, respectively; bands indicated by arrows in lanes 2 and 4 were recombinant D-LDH; the theoretical protein size was 37.2 kDa; bands indicated by arrows in lanes 3 and 5 were recombinant HPPR; the theoretical protein size was 35.4 kDa. The same amounts of cells were loaded in all lanes. All cells were induced using 0.5 mM IPTG at 28 °C and 150 rpm for 6 h.
Figure 6
Figure 6
(a) Effects of pH on SAA production yield (the SAA yield at pH 5.5 was set as 100%). (b) Effects of temperature on SAA production yield (the SAA yield at 44 °C was set as 100%). Data represent the means ± SD from three independent determinations.
Figure 7
Figure 7
Effect of permeabilized BL21(DE3)-pETDuet-dldh-fdh cell concentration on SAA.

Similar articles

Cited by

References

    1. Zhao G.R., Zhang H.M., Ye T.X., Xiang Z.J., Yuan Y.J., Guo Z.X., Zhao L.B. Characterization of the Radical Scavenging and Antioxidant Activities of Danshensu and Salvianolic Acid B. Food Chem. Toxicol. 2008;46:73–81. doi: 10.1016/j.fct.2007.06.034. - DOI - PubMed
    1. Zhao B.L., Jiang W., Zhao Y., Hou J.W., Xin W.J. Scavenging Effects of Salvia Miltiorrhiza on Free Radicals and Its Protection for Myocardial Mitochondrial Membranes from Ischemia-Reperfusion Injury. Biochem. Mol. Biol. Int. 1996;38:1171–1182. - PubMed
    1. Tang M.-K., Ren D.-C., Zhang J.-T., Du G.-H. Effect of Salvianolic Acids from Radix Salviae Miltiorrhizae on Regional Cerebral Blood Flow and Platelet Aggregation in Rats. Phytomedicine. 2002;9:405–409. doi: 10.1078/09447110260571634. - DOI - PubMed
    1. Huang Z.S., Zeng C.L., Zhu L.J., Jiang L., Li N., Hu H. Salvianolic Acid A Inhibits Platelet Activation and Arterial Thrombosis via Inhibition of Phosphoinositide 3-Kinase. J. Thromb. Haemost. 2010;8:1383–1393. doi: 10.1111/j.1538-7836.2010.03859.x. - DOI - PubMed
    1. Song Q., Zhang Y., han X., Zhang Y., Zhang X., Gao Y., Zhang J., Chu L., Zhao S. Potential Mechanisms Underlying the Protective Effects of Salvianic Acid A against Atherosclerosis in Vivo and Vitro. Biomed. Pharmacother. 2019;109:945–956. doi: 10.1016/j.biopha.2018.10.147. - DOI - PubMed

LinkOut - more resources